Standout Papers

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis ... 2015 2026 2018 2022 640
  1. Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial (2015)
    Iain B. McInnes, Philip J. Mease et al. The Lancet
  2. Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis (2015)
    Philip J. Mease, Iain B. McInnes et al. New England Journal of Medicine
  3. Enthesitis: from pathophysiology to treatment (2017)
    Georg Schett, Rik Lories et al. Nature Reviews Rheumatology

Immediate Impact

2 by Nobel laureates 17 from Science/Nature 68 standout
Sub-graph 1 of 20

Citing Papers

Rheumatoid arthritis: pathogenesis and therapeutic advances
2024 Standout
Bispecific T cell engager therapy for refractory rheumatoid arthritis
2024 Standout

Works of Bruce Kirkham being referenced

Rheumatoid Arthritis — Anti-TNF
2015
Ectopic Lymphoid Structures Support Ongoing Production of Class-Switched Autoantibodies in Rheumatoid Synovium
2009

Author Peers

Author Last Decade Papers Cites
Bruce Kirkham 3938 3769 2024 141 6.9k
Thasia Woodworth 4066 2293 1481 84 7.3k
Bernhard Manger 3378 3114 1230 197 7.4k
Atul Deodhar 6572 4813 2776 297 8.8k
Francesco Ciccia 3003 2780 1623 227 6.9k
Raffaele Scarpa 3911 3065 1601 222 6.2k
Christian Antoni 5561 4209 2790 48 8.9k
Gerd‐Rüdiger Burmester 4420 3096 1367 153 8.5k
G Triolo 2196 2080 1265 207 5.6k
Axel J. Hueber 2312 2600 824 153 5.7k
Panayiotis G. Vlachoyiannopoulos 5265 1803 2390 116 8.0k

All Works

Loading papers...

Rankless by CCL
2026